Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-20

Clinical Trial Update: Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency [Phase 4]

View source ↗

Summary

Phase 4 non-inferiority trial comparing Diosmin 600 mg alone versus Diosmin combined with Hesperidin in symptomatic chronic venous insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diosmin (Diosmin)
  • Diosmin-Hesperidin

Snippet

Sponsor: Fundação Educacional Serra dos Órgãos | Conditions: Venous Insufficiency | Phase 4 | Status: COMPLETED